Michael Graz | Interim Chief Scientific Officer
Innoture

I’m an entrepreneur working at the intersection of microbiology, biofilms, and med‑tech product development. I founded Biophys, a UK-based firm which has its own microbiology and cell biology research facilities and has a portfolio of medical devices and diagnostic products. Furthermore, I serve as Interim CSO for Innoture, developing MAP platform technology, and as CEO of Disperazol Pharma, which develops antibiofilm compounds for Gram-negative infections. Previously, I’ve led or advised companies in natural enzyme extraction, breath-based diagnostics, molecular tests for food borne pathogens, and plant-derived antimicrobials, including securing FDA Orphan Drug Designation for a first-in-class anti-virulence agent. I remain active in policy and research through UK parliamentary science work and international biofilm research collaborations.